AgomAb Therapeutics (AGMB Proposed) of Belgium is the latest biotech deal to join next week’s growing IPO Calendar – a heat wave of healthcare IPOs for the first week of February. The company disclosed the terms for its $200 million IPO early today in an SEC filing: 12.5 million American Depositary Shares (ADS) at a price range of $15.00 to $17.00 to raise $200 million – if priced at the $16.00 mid-point of its range, according to its F-1 filing dated Jan. 29, 2026. AgomAb Therapeutics‘ IPO brings the healthcare deal count for next week to three IPOs – or half of the $100 million-plus deals on tap for the first week of February so far. These three biotech IPOs intend to raise a total of $700 million.
J.P. Morgan, Morgan Stanley, Leerink Partners and Van Lanschot Kempen are the joint book-runners of the AgomAb Therapeutics IPO.
AgomAb Therapeutics‘ IPO is a NASDAQ listing. (Please see the IPO Calendar for the pricing date.)
At pricing, AgomAb Therapeutics would have a market cap of $779.79 million.
The company, based in Antwerp, is raising money to fund Phase 2 clinical trials of its two leading drug candidates: ontunisertib (AGMB-129), a pill to treat people with Crohn’s disease with fibrostenosis, and AGMB-447, an inhaled treatment for people with idiopathic pulmonary fibrosis (IPF).
The IPO Calendar next week includes two other IPOs from the healthcare sector that intend to raise $500 million total:
- Eikon Therapeutics (EIKN Proposed), a clinical biotech developing treatments for advanced melanoma, non-small cell lung cancer (NSCLC), ovarian cancer and breast cancer, with lead book-runners J.P. Morgan and Morgan Stanley, along with joint book-runners BofA Securities and Cantor, aiming to raise $300 million, and
- Veradermics (MANE Proposed), a clinical biotech developing minoxidil to treat pattern hair loss in men and women, with lead book-runners Jefferies and Leerink, along with joint book-runners Citigroup and Cantor, aiming to raise $200 million.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.